Biomedical Engineering Reference
In-Depth Information
[42] Liu Y, miyoshi H, Nakamura m. Nanomedicine for drug delivery and imaging: a prom-
ising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Int J Cancer 2007;
120
:2527-2537.
[43] ganta S, Devalapally H, Shahiwala A, Amiji m. A review of stimuli-responsive nanocar-
riers for drug and gene delivery. J Control Release 2008;
126
:187-204.
[44] park YS. Tumor-directed targeting of liposomes. biosci Rep 2002;
22
:267-281.
[45] Hong R-L, Huang C-J, Tseng Y-L, pang Vf, Chen S-T, Liu J-J, Chang f-H. Direct
comparison of liposomal doxorubicin with or without polyethylene glycol coating in
C-26 tumor-bearing mice. Clin Cancer Res 1999;
5
:3645-3652.
[46] gabizon A, price DC, Huberty J, bresalier RS, papahadjopoulos D. effect of liposome
composition and other factors on the targeting of liposomes to experimental tumors:
biodistribution and imaging studies. Cancer Res 1990;
50
:6371-6378.
[47] papahadjopoulos D, Allen Tm, gabizon A, mayhew e, matthay K, Huang SK,
Lee KD, Woodle mC, Lasic DD, Redemann C. Sterically stabilized liposomes:
improvements in pharmacokinetics and antitumor therapeutic efficacy. proc Natl
Acad Sci U S A 1991;
88
:11460-11464.
[48] Xiong X-b, Huang Y, Lu W-l, Zhang H, Zhang X, Zhang Q. enhanced intracellular
uptake of sterically stabilized liposomal doxorubicin in vitro resulting in improved anti-
tumor activity
in vivo
. pharm Res 2005;
22
:933-939.
[49] Harrington KJ, mohammadtaghi S, Uster pS, glass D, peters Am, Vile Rg, Stewart
JSW. effective targeting of solid tumors in patients with locally advanced cancers by
radiolabeled pegylated liposomes. Clin Cancer Res 2001;
7
:243-254.
[50] Umeda I, Tani K, Tsuda K, Kobayashi m, Ogata m, Kimura S, Yoshimoto m, Kojima S,
moribe K, Yamamoto K, moriyama N, fujii H. High resolution SpeCT imaging for
visualization of intratumoral heterogeneity using a SpeCT/CT scanner dedicated
for small animal imaging. Ann Nucl med 2012;
26
:67-76.
[51] Ogihara-Umeda I, Sasaki T, Kojima S, Nishigori H. Optimal radiolabeled liposomes for
tumor imaging. J Nucl med 1996;
37
:326-332.
[52] elbayoumi T, Torchilin V. Tumor-targeted immuno-liposomes for delivery of chemother-
apeutics and diagnostics. J pharm Innov 2008;
3
:51-58.
[53] erdogan S, Roby A, Torchilin Vp. enhanced tumor visualization by γ-scintigraphy
with 111In-labeled polychelating-polymer-containing immunoliposomes. mol pharm
2006;
3
:525-530.
[54] Kleiter mm, Yu D, mohammadian LA, Niehaus N, Spasojevic I, Sanders L, Viglianti bL,
Yarmolenko pS, Hauck m, petry NA, Wong TZ, Dewhirst mW, Thrall De. A tracer dose
of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratu-
moral doxil extravasation. Clin Cancer Res 2006;
12
:6800-6807.
[55] bao A, phillips WT, goins b, Zheng X, Sabour S, Natarajan m, Ross Woolley f, Zavaleta C,
Otto RA. potential use of drug carried-liposomes for cancer therapy via direct intratumoral
injection. Int J pharm 2006;
316
:162-169.
[56] Laverman p, Dams eTm, Oyen WJg, Storm g, Koenders eb, prevost R, van der meer
JWm, Corstens fHm, boerman OC. A novel method to label liposomes with 99mtc by
the hydrazino nicotinyl derivative. J Nucl med 1999;
40
:192-197.
[57] Zielhuis SW, Seppenwoolde JH, mateus VA, bakker CJ, Krijger gC, Storm g,
Zonnenberg bA, van het Schip AD, Koning gA, Nijsen Jf. Lanthanide-loaded liposomes
for multimodality imaging and therapy. Cancer biother Radiopharm 2006;
21
:520-527.
Search WWH ::
Custom Search